NEW to ISOQOL: E-learning is here!

ISOQOL is excited to launch our new e-learning program! There are currently three established education programs, including online courses, webinars, and virtual symposium recordings. ISOQOL’s education initiatives are open to anyone with an interest in the theory,...

Incorporating PRO data to optimize dose in anti-cancer therapies

Description Exposure-response (E-R) analysis to inform optimal dose in early clinical development of oncology products has traditionally relied on adverse event-based clinician-reported Common Terminology Criteria for Adverse Events. As part of a broader effort to...